{
    "nct_id": "NCT04176497",
    "official_title": "Image-Adapted Target Volumes Using 68Ga-HBED-CC PSMA-PET/MRI for Unfavorable-Risk Prostate Cancer Patients Receiving Radiation",
    "inclusion_criteria": "* Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.\n* Histologically confirmed prostate adenocarcinoma\n* Unfavorable intermediate or high-risk, based on the National Comprehensive Cancer Network (NCCN) criteria, with appropriate staging (e.g. bone scan) as defined in the protocol.\n* Subject has adequate performance status as defined by ECOG performance status of 0-2.\n* Subject is willing and able to comply with the protocol as determined by the Treating Investigator.\n* Subject speaks English (quality of life instrument is validated in English).\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Contraindications for MRI\n* Other prior or concomitant malignancies with the exception of:\n\n  * Non-melanoma skin cancer\n  * Other cancer for which the subject has been disease free for â‰¥5 years before the first study treatment and of low potential risk for recurrence.\n* Inflammatory bowel disease\n* Absolute contraindications to brachytherapy per American Brachytherapy Society: unacceptable operative risk, absence of rectum, large TURP defects",
    "miscellaneous_criteria": ""
}